Covid vaccine will be available by the end of 2021: Sanofi CEO

Sanofi halts development of its Covid mRNA vaccineПодробнее

U.S. Likely to Get Sanofi's Covid-19 Vaccine First If It SucceedsПодробнее

Sanofi CEO on breakthroughs in cancer research, COVID-19 vaccine development, and drug pricingПодробнее

Covid vaccine by Sanofi-GSK delayed after disappointing results in older patientsПодробнее

Sanofi CEO on coronavirus vaccine development and the pressure 'to get it right'Подробнее

Sanofi: Our vaccine could serve as an excellent booster shotПодробнее

Sanofi, GSK say Covid-19 vaccine won't be ready until late 2021Подробнее

Coronavirus: Sanofi CEO explains its multi-pronged effort to treat and test for COVID-19Подробнее

Sanofi expecting for approval on Covid-19 vaccine in the beginning of 2021, also European markets upПодробнее

Sanofi CEO on two-pronged approach to developing Covid-19 vaccineПодробнее

Sanofi and GSK see positive interim results for their Covid vaccine in trialsПодробнее

Sanofi CEO Paul Hudson on COVID-19 and potential vaccine (Full Stream 11/10)Подробнее

Sanofi sees vaccine trial completed in first quarterПодробнее

Sanofi Has Two Covid Vaccines in Clinical TrialsПодробнее

Coronavirus vaccine: By the end of 2021 we should be in a good place: PhysicianПодробнее

Sanofi eyes approval of COVID-19 vaccine by first half of 2021Подробнее

No Covid-19 vaccine expected ‘until 2021’, virologist says amid Sanofi rowПодробнее

Sanofi to help produce doses of Pfizer-BioNTech Covid vaccineПодробнее

Glaxo Joins Forces With Sanofi to Develop Coronavirus VaccineПодробнее